1958: Americas Response to Sputnik U.S. Defense budget increased to - - PowerPoint PPT Presentation

1958 america s response to sputnik
SMART_READER_LITE
LIVE PREVIEW

1958: Americas Response to Sputnik U.S. Defense budget increased to - - PowerPoint PPT Presentation

1958: Americas Response to Sputnik U.S. Defense budget increased to a peace- time record $74 billion DARPA - Defense Advanced Research Projects Agency National Defense Education Act $3 billion invested in high schools and


slide-1
SLIDE 1
slide-2
SLIDE 2
slide-3
SLIDE 3
  • U.S. Defense budget increased to a peace-

time record $74 billion

  • DARPA - Defense Advanced Research

Projects Agency

  • National Defense Education Act
  • $3 billion invested in high schools and

universities throughout the 1960s

  • NASA – National Aeronautics and Space

Administration

Source: PC World

1958: America’s Response to Sputnik

slide-4
SLIDE 4

1969: “The Eagle has landed.”

slide-5
SLIDE 5

Nixon Declares War on Cancer - 1971

slide-6
SLIDE 6

Each life is priceless… but in economic terms, over the past two centuries, as much as 50%

  • f all economic

growth can be traced to advances in health.

The Value of Health

slide-7
SLIDE 7

Worldwide Life Expectancy

Four million years produced an 11-year increase from 20 to 31.

31 72 1900 2018

118 years produced a 41- year increase.

James Carey: Longevity; United Nations Development Program

slide-8
SLIDE 8
  • Chicken pox
  • Diphtheria
  • H. influenza-caused

invasive diseases

  • Measles
  • Pertussis
  • Pneumococcal disease
  • Polio
  • Tetanus
  • Typhoid fever
  • Yellow fever
  • Smallpox

Source: Discovery Fit & Health

Some Major Diseases Now Mostly Controlled

slide-9
SLIDE 9
  • Vastly improved sanitation
  • Development of antibiotics
  • Implementation of vaccines
  • Progress against heart disease
  • Investment in bioscience research

What caused the increase?

slide-10
SLIDE 10

The National Cancer Summit 1995

The March of Progress

Milken Family Foundation Cancer Research Awards 1970s/1980s CaP CURE PCF 1993 The MARCH in Washington 1998

slide-11
SLIDE 11

Innovation Retreat / NCATS 2011 Partnering For Cures 2009 - current FasterCures 2003 - 2015 NIH Budget Doubles 1998-2003

The March of Progress

slide-12
SLIDE 12

Celebration of Science 2012 CDC Conference 2014 21st Century Cures Act 2016 Milken Institute School of Public Health 2014

The March of Progress

slide-13
SLIDE 13

The March of Progress

PCF-VA Veterans Health Initiative 2016 - current Future of Health Summit 2017 - current Giving Pledge Learning Session February 2017

slide-14
SLIDE 14

Direct Health Care Costs for Treatment of Chronic Illnesses and Indirect Productivity Losses, 2016 ($ Billions)

Equivalent to 19.6% of GDP

Diabetes $526.6 Cardiovascular Conditions $1,461.3 Alzheimers Disease $268.3 Arthritis & Back Pain $843.4 Cancers $281.0 Other Conditions $267.5

Total direct costs = $3.7 trillion

Cost of Chronic Diseases: $3.7 Trillion

Source: The Costs of Obesity in the U.S., Milken Institute, July 30, 2018

slide-15
SLIDE 15

Condition

Costs (in $ Millions)

Direct Indirect TOTAL

Alzheimer's or Vascular Dementia $73,572 $32,606 $106,178 Asthma $10,564 $16,234 $26,798 Breast Cancer $5,900 $3,669 $9,569 Chronic Back Pain $38,476 $217,291 $255,768 Colorectal Cancer $6,151 $5,425 $11,576 Congestive Heart Failure $5,201 $2,039 $7,239 Coronary Heart Disease $22,700 $39,315 $62,015 Diabetes Type 2 $120,707 $214,500 $335,208 Dyslipidemia $28,619 † $28,619 End Stage Renal Disease $3,716 †† $3,716 Endometrial Cancer $189 $158 $347 Esophageal Adenocarcinoma $970 $92 $1,061 Gallbladder Cancer $22 $17 $39 Gallbladder Disease $26,863 $27,401 $54,264 Gastric Cardia Adenocarcinoma $1,433 $136 $1,568 Hypertension $29,323 $432,230 $461,553 Liver Cancer $87 $67 $154 Osteoarthritis $86,480 $215,303 $301,783 Ovarian Cancer $1,152 $152 $1,304 Pancreatic Cancer $146 $738 $884 Prostate Cancer $1,983 $13,411 $15,393 Renal Cancer $2,254 $559 $2,813 Stroke $14,148 $14,527 $28,674 $480,654 $1,235,869 $1,716,523

Source: The Costs of Obesity in the U.S., Milken Institute, July 30, 2018

Total Costs of Obesity and Overweight, 2016

slide-16
SLIDE 16

We have entered a new Age of Medicine.

  • Immunology
  • Precision medicine
  • Genomics
  • Powerful diagnostic tools
slide-17
SLIDE 17

When robotic surgery is performed by a certified provider with advanced training and skill …

  • Less blood loss, less trauma to the body, less

scarring.

  • Hospital stays are shorter and recovery times

much faster.

Source: University of Kentucky HealthCare

Minimally Invasive Robotic Surgery

slide-18
SLIDE 18

400,000 robotic surgeries were performed in the U.S. in 2012. The rate of robotic surgeries is increasing 25% per year. By 2020, the global medical robotic system market will reach $18 billion; compound annual growth rate will be 12.7%.

Source: Becker’s ASC Review 7/23/15; 11 Things to Know About Robotic Surgery

Robotic Surgery

slide-19
SLIDE 19
  • Two highly skilled pathologists

assessing the same slide will agree

  • nly about 60% of the time.
  • Machine-learning predicted patient

survival times better than the standard practice of pathologists.

Source: Stanford University School of Medicine

Pathologist vs. Computer

slide-20
SLIDE 20

Sequencing the Human Genome

2003:

  • 13 years
  • $3 billion

Today:

  • A few hours
  • Approaching $1,000
slide-21
SLIDE 21

The Origins of Immunotherapy

Reported a major breakthrough in the development of successful gene therapy that for the first time in history harnessed the body's own immune system to shrink tumors.

  • Dr. Rosenberg is now chief of

surgery at the National Cancer Institute.

Steven Rosenberg, M.D.

slide-22
SLIDE 22

Arie Belldegrun, MD

Commercialization of Rosenberg’s Work

slide-23
SLIDE 23

Milken Institute’s Concept to Commercialization

1. University of Utah 2. Columbia University 3. University of Florida 4. Brigham Young University 5. Stanford University 6. University of Pennsylvania 7. University of Washington 8. MIT 9. California Inst. of Technology

  • 10. Carnegie Mellon University
slide-24
SLIDE 24

PCF Leverage in New Cancer Drugs

slide-25
SLIDE 25

Impact of PCF Young Investigators

10 FDA-approved treatments for prostate cancer since 2010.

  • Provenge: stimulates tumor immunity
  • Xgeva: improves quality of life by reducing side effects
  • Jevtana: chemotherapy that kills prostate cancer cells
  • Zytiga: reduces testosterone, resulting in longer life
  • Xtandi: blocks testosterone’s cancer targets and prolongs life
  • Xofigo: results in less medication to control bone pain
  • Erleada: treatment for those who fail testosterone reduction
  • Zytiga + Prednisone: delays cancer progression by 18 months
  • Pembrolizumab: precision immunotherapy for solid tumors
  • Xtandi: secondary approval for non-metastatic CRPC
slide-26
SLIDE 26

Heritage Provider Network: The Challenge

slide-27
SLIDE 27

Heritage Provider Network: The Solution

slide-28
SLIDE 28

“Never doubt that a small group of thoughtful, committed citizens can change the world: indeed, it’s the only thing that does.”

  • Margaret Mead